As of May 23, 2025, Zenabis Global Inc (ZENA.TO) reports a EV/EBITDA of N/A.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Zenabis Global Inc's EV/EBITDA to Peers
To better understand Zenabis Global Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Zenabis Global Inc (ZENA.TO) | - |
| M2bio Sciences Inc (WUHN) | 38.76 |
| Harrow Health Inc (HROW) | 33.35 |
| Alimera Sciences Inc (ALIM) | 31.17 |
| Cipher Pharmaceuticals Inc (CPH.TO) | 27.50 |
| Emmaus Life Sciences Inc (EMMA) | 19.59 |
Compared to its competitors, Zenabis Global Inc's EV/EBITDA is difficult to compare due to insufficient data.